Phase II study of mitoguazone, cyclophosphamide, doxorubicin, vincristine and prednisone for patients with diffuse histologic subtypes of non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Study (PE481) (Q77123006)
Jump to navigation
Jump to search
scientific article published on 01 August 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of mitoguazone, cyclophosphamide, doxorubicin, vincristine and prednisone for patients with diffuse histologic subtypes of non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Study (PE481) |
scientific article published on 01 August 1998 |
Statements
Phase II study of mitoguazone, cyclophosphamide, doxorubicin, vincristine and prednisone for patients with diffuse histologic subtypes of non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Study (PE481) (English)
D F Moore
J M Bennett
S E Vogl
J E Harris
S Luger
M M Oken